- Home Page
- EMVDA
- EURHAVAC
- Malaria - The Disease
- Press Releases
- EMVI Statutes
- Board Members and Scientific Advisory Committee Members
- Memoranda of Understanding and Intent
- EMVI Strategy
- Project Portfolio
- Annual Reports
- The Donors
- Mid-Term Review 2005
- Directives - Guidelines - Regulations
- Meeting Reports
- Procedures
- Calls
- Vacancies
Vacancies
EMVI has currently two vacancies for a Project Manager and Trainee Project Manager. Please see under Vacancies.
NEWS
Contributions from donors - 2008
€ 1 000 000 - Irish Aid, Republic of ireland
€ 268 000 - Danida, Denmark
EMVI sends grateful thanks to its donors for their invaluable support to the important mission of EMVI.
BACKGROUND
The European Malaria Vaccine Initiative, EMVI was established in 1998 by the European Commission and interested European Union Member States, in order to address identified structural deficiencies in public funded malaria vaccine development.
The aim of EMVI is to provide a mechanism through which the development of experimental malaria vaccines can be accelerated within Europe and in developing countries.
EMVI shall facilitate and contribute financially and technically to nationally and internationally funded malaria vaccine research and development, and will provide a mechanism to see candidate molecules through to limited industrial production and clinical trials in close collaboration with the African Malaria Network Trust (AMANET).
EMVI will provide a forum for scientists and policy makers engaged in malaria vaccine research and development.
Reference: Hagan P, Bjorvatn B and Jepsen S. European Malaria Vaccine Initiative. Parasitol Today 15: 47-48, 1999